Dr. Hoenle AG (HNL) AI Stock Analysis

Dr. Hoenle AG

(BX Swiss:HNL)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue reboundThe sharp TTM revenue rebound indicates renewed demand for Hönle’s industrial UV and LED solutions and provides a stronger base for operating leverage. If sales momentum persists, the enlarged revenue base could support better utilization, product investment, and eventual margin recovery.

Negative Factors

Severe margin pressureThe collapse in gross margin shows that the strong sales rebound has not yet translated into attractive economics. Persistently negative net income limits reinvestment capacity and leaves the business dependent on a successful margin recovery before growth can produce durable shareholder returns.

Dr. Hoenle AG Business Overview & Revenue Model

Company Description

Dr. Hönle AG is a global provider specializing in industrial ultraviolet (UV) technologies and related systems, with operations spanning Germany and international markets. The company organizes its business into three main segments: Adhesives, Equipm...

Dr. Hoenle AG Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

CH:HNL against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DE:SMHN	62Neutral	EUR 973.94M	35.14	8.73%	0.08%	-15.45%	-51.36%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
DE:SNG	52Neutral	EUR 102.75M	-8.85	18.15%	―	-6.77%	-47.94%
DE:LPK	46Neutral	EUR 251.09M	-11.02	-33.16%	―	-26.24%	-2180.10%
DE:MXHN	42Neutral	EUR 102.70M	-48.63	-1.09%	―	-8.60%	-107.57%

* General Sector Average

Performance Comparison

CH:HNL and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:LPK	LPKF Laser & Electronics	10.40	4.26	69.38%
DE:M5Z	Manz AG	0.01	-0.05	-82.76%
DE:MXHN	MAX Automation	2.26	-3.52	-60.89%
DE:SNG	Singulus Technologies	12.50	10.98	725.08%
DE:SMHN	Suss Microtec Se	51.20	24.11	89.01%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Dr. Hoenle AG AI Stock Analysis